The VISAGE consortium's efforts coincide with a push in Germany to allow DNA phenotyping and biogeographical ancestry testing in criminal investigations.
The change will be felt most immediately in Europe, where the Dutch molecular diagnostics company recently secured a CE-IVD mark for its MammaPrint BluePrint kit.
A European Union lawyer argues that gene-edited crops should be exempt from genetically modified organism laws in the EU, the Guardian reports.
Over the next three years, the company and its partners will assess the OneRNA platform to diagnose bladder cancer, select treatment, and measure response and recurrence.
The European Union and the UK have developed an agreement that would enable EU researchers to stay in the UK post-Brexit, Science reports.
The new European initiative promises to deliver multiple new tests and methods for improving the treatment of breast cancer and rectal cancer.
The firm will launch two new analysis modules for its Genetic Information Management Suite next year, in addition to a new pharmacogenomics mobile application.
A new report suggests the UK's stature in science and research could fall post-Brexit, the Guardian reports.
Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.
British and foreign researchers brace for the effects of the UK leaving the EU, the Associated Press reports.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.